Dudediligence.

Quince Therapeutics, Inc

QNCXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$173,211

1 notice · 50,000 sh

Oct 2025 to Oct 2026

Reported ·

$173,500

1 sale · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

The one reported sale does not carry the 10b5-1 box. It is 4.92% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2025-12-26: LUCA BENATTI, Form 1442025-12-26: Benatti Luca, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2025-12-26LUCA BENATTI, OFFICER$173,211
50,000 shno plan date144 ↗
Form 4, 2025-12-29: sold 50,000 at $3.47 Form 4 ↗